4
How to cite this paper
APA: Jagannath, K. (2020). Synthesis and anti-tuberculosis studies of 10-phenyl sulfonyl-2-alkyl/aryl- 4, 10 dihydrobenzo [4, 5] imidazo [1, 2-a] pyrimidin-4-one derivatives. Current Chemistry Letters, 9(1), 1-8.
Chicago/Turabian: Jagannath, K. 2020. "Synthesis and anti-tuberculosis studies of 10-phenyl sulfonyl-2-alkyl/aryl- 4, 10 dihydrobenzo [4, 5] imidazo [1, 2-a] pyrimidin-4-one derivatives." Current Chemistry Letters 9, no. 1 (2020): 1-8.
AMA: Jagannath, K. Synthesis and anti-tuberculosis studies of 10-phenyl sulfonyl-2-alkyl/aryl- 4, 10 dihydrobenzo [4, 5] imidazo [1, 2-a] pyrimidin-4-one derivatives. Current Chemistry Letters. 2020;9(1):1-8.
References
1. World Health Organization, Global Tuberculosis Report, (2013), http://www.who.int/tb/publications/global_report/en/
2. Abdel-hafez, A. A. (2007) Benzimidazole Condensed Ring Systems: New Synthesis and Antineoplastic Activity of Substituted 3,4-Dihydro- and 1,2,3,4- Tetrahydro-benzo[4,5]imidazo[1,2-a]pyrimidine Derivatives. Arch. Pharm. Res. 30, 678-84.
3. Dalla Via, L., Gia, O., Magno, S. M., Da Settimo, A., Marini, A. M., Primofiore, G., ... & Salerno, S. (2001) Synthesis, in vitro antiproliferative activity and DNA-interaction of benzimidazoquinazoline derivatives as potential anti-tumor agents. Il Farmaco, 56(3), 159-167.
4. Starčević, K., Kralj, M., Ester, K., & Karminski-Zamola, G. (2007) Synthesis and cytostatic evaluation of pyridopyrimidobenzimidazole derivatives. Heterocycles, 71(3), 647-656.
5. Chiba, T., Shigeta, S., & Numazaki, (1995) Inhibitory effect of Pyridobenzazoles on virus replication in vitro Y. Biol. Pharm. Bull. 18, 1081-83.
6. Nawrocka, W., Zimecki, M., Kuznicki, T., & Kowalska, M. W. (1999) Immunotropic properties of 2-aminobenzimidazole derivatives in cultures of human peripheral blood cells, Part 5. Arch. Pharm. Pharm. Med. Chem., 332(3), 85–90.
7. Nawrocka, W., & Zimecki, M. (1998) Synthesis and Immunotropic Activity of Some 2‐Aminobenzimidazoles, Part 4. Arch. Pharm. Pharm. Med. Chem, 331(7-8), 249–253.
8. Puttaraju, K. B., Shivashankar, K., Mahendra, M., Rasal, V. P., Vivek, P. N. V., Rai, K., & Chanu, M. B. (2013). Microwave assisted synthesis of dihydrobenzo [4, 5] imidazo [1, 2-a] pyrimidin-4-ones; synthesis, in vitro antimicrobial and anticancer activities of novel coumarin substituted dihydrobenzo [4, 5] imidazo [1, 2-a] pyrimidin-4-ones. Eur. J. Med. Chem., 69, 316-322.
9. Kumar, V., Kalalbandi, A., Seetharamappa, J., Katrahalli, U., and Bhat, K. G. (2014) European Journal of Medicinal Chemistry Synthesis, crystal studies , anti-tuberculosis and cytotoxic studies of 1- [( 2 E ) -3-phenylprop-2-enoyl ] -1 H -benzimidazole derivatives. Eur. J. Med. Chem., 79, 194–202.
10. Ali, A., Reddy, G. K. K., Cao, H., Anjum, S. G., Nalam, M. N., Schiffer, C. A., & Rana, T. M. (2006). Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands. J. Med. Chem., 49(25), 7342-7356.
11. McCarroll, A. J., Bradshaw, T. D., Westwell, A. D., Matthews, C. S., & Stevens, M. F. G. (2007) Quinols as novel therapeutic agents. 7.1 Synthesis of antitumor 4-[1-(arylsulfonyl-1H-indol-2-yl)]-4-hydroxycyclohexa-2,5-dien-1-ones by Sonogashira reactions. J. Med. Chem., 50(7), 1707–10.
12. Wilkinson, B. L., Bornaghi, L. F., Houston, T. a, Innocenti, A., Vullo, D., Supuran, C. T., & Poulsen, S.-A. (2007) Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of phenyl sulfonamides. J. Med. Chem., 50(7), 1651–7.
13. Supuran, C. T., & Scozzafava, A. (2000) Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin. Ther. Pat., 10(5), 575–600.
14. Schenone, S., Brullo, C., Bruno, O., Bondavalli, F., Ranise, A., Filippelli, W., Rinaldi, B., et al. (2006) New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities. Bioorg. Med. Chem., 14(6), 1698–705.
15. Ghorab, M. M., Ragab, F. A., Heiba, H. I., & El-hazek, R. M. (2011) European Journal of Medicinal Chemistry Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety. Eur. J. Med. Chem, 46(10), 5120–5126. doi.org/10.1016/j.ejmech.2011.08.026
16. Liou, J. P., Hsu, K. S., Kuo, C. C., Chang, C. Y., & Chang, J. Y. (2007) A novel oral indoline-sulfonamide agent, J30, exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule. J. Pharmacol. Exp. Ther, 323(1), 398-405.
17. Chen, Z., Xu, W., Liu, K., Yang, S., Fan, H., Bhadury, P. S., ... & Zhang, Y. (2010) Synthesis and Antiviral Activity of 5 (4 Chlorophenyl)-1, 3, 4-Thiadiazole Sulfonamides. Molecules, 15(12), 9046-9056.
18. Scozzafava, A., Owa, T., Mastrolorenzo, A., & Supuran, C. T. (2003) Anticancer and antiviral sulfonamides. Curr. Med. Chem., 10(11), 925-953.
19. Shoaib Ahmad Shah, S., Rivera, G., & Ashfaq, M. (2013). Recent advances in medicinal chemistry of sulfonamides. Rational design as anti-tumoral, anti-bacterial and anti-inflammatory agents. Mini Rev. Med. Chem., 13(1), 70-86.
20. Jagannath, K. V, Krishnamurthy, G., & Raghavaiah P. (2018) Synthesis, crystal structure and thermal studies of 2-(propan-2-yl) pyrimido [1,2-a] benzimidazol -4(10H)-one. Proceedings of Int. Conference Recent Advances in Materials Science and Biophysics (RAMSB)-2018, 1, 13-17.
2. Abdel-hafez, A. A. (2007) Benzimidazole Condensed Ring Systems: New Synthesis and Antineoplastic Activity of Substituted 3,4-Dihydro- and 1,2,3,4- Tetrahydro-benzo[4,5]imidazo[1,2-a]pyrimidine Derivatives. Arch. Pharm. Res. 30, 678-84.
3. Dalla Via, L., Gia, O., Magno, S. M., Da Settimo, A., Marini, A. M., Primofiore, G., ... & Salerno, S. (2001) Synthesis, in vitro antiproliferative activity and DNA-interaction of benzimidazoquinazoline derivatives as potential anti-tumor agents. Il Farmaco, 56(3), 159-167.
4. Starčević, K., Kralj, M., Ester, K., & Karminski-Zamola, G. (2007) Synthesis and cytostatic evaluation of pyridopyrimidobenzimidazole derivatives. Heterocycles, 71(3), 647-656.
5. Chiba, T., Shigeta, S., & Numazaki, (1995) Inhibitory effect of Pyridobenzazoles on virus replication in vitro Y. Biol. Pharm. Bull. 18, 1081-83.
6. Nawrocka, W., Zimecki, M., Kuznicki, T., & Kowalska, M. W. (1999) Immunotropic properties of 2-aminobenzimidazole derivatives in cultures of human peripheral blood cells, Part 5. Arch. Pharm. Pharm. Med. Chem., 332(3), 85–90.
7. Nawrocka, W., & Zimecki, M. (1998) Synthesis and Immunotropic Activity of Some 2‐Aminobenzimidazoles, Part 4. Arch. Pharm. Pharm. Med. Chem, 331(7-8), 249–253.
8. Puttaraju, K. B., Shivashankar, K., Mahendra, M., Rasal, V. P., Vivek, P. N. V., Rai, K., & Chanu, M. B. (2013). Microwave assisted synthesis of dihydrobenzo [4, 5] imidazo [1, 2-a] pyrimidin-4-ones; synthesis, in vitro antimicrobial and anticancer activities of novel coumarin substituted dihydrobenzo [4, 5] imidazo [1, 2-a] pyrimidin-4-ones. Eur. J. Med. Chem., 69, 316-322.
9. Kumar, V., Kalalbandi, A., Seetharamappa, J., Katrahalli, U., and Bhat, K. G. (2014) European Journal of Medicinal Chemistry Synthesis, crystal studies , anti-tuberculosis and cytotoxic studies of 1- [( 2 E ) -3-phenylprop-2-enoyl ] -1 H -benzimidazole derivatives. Eur. J. Med. Chem., 79, 194–202.
10. Ali, A., Reddy, G. K. K., Cao, H., Anjum, S. G., Nalam, M. N., Schiffer, C. A., & Rana, T. M. (2006). Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands. J. Med. Chem., 49(25), 7342-7356.
11. McCarroll, A. J., Bradshaw, T. D., Westwell, A. D., Matthews, C. S., & Stevens, M. F. G. (2007) Quinols as novel therapeutic agents. 7.1 Synthesis of antitumor 4-[1-(arylsulfonyl-1H-indol-2-yl)]-4-hydroxycyclohexa-2,5-dien-1-ones by Sonogashira reactions. J. Med. Chem., 50(7), 1707–10.
12. Wilkinson, B. L., Bornaghi, L. F., Houston, T. a, Innocenti, A., Vullo, D., Supuran, C. T., & Poulsen, S.-A. (2007) Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of phenyl sulfonamides. J. Med. Chem., 50(7), 1651–7.
13. Supuran, C. T., & Scozzafava, A. (2000) Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin. Ther. Pat., 10(5), 575–600.
14. Schenone, S., Brullo, C., Bruno, O., Bondavalli, F., Ranise, A., Filippelli, W., Rinaldi, B., et al. (2006) New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities. Bioorg. Med. Chem., 14(6), 1698–705.
15. Ghorab, M. M., Ragab, F. A., Heiba, H. I., & El-hazek, R. M. (2011) European Journal of Medicinal Chemistry Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety. Eur. J. Med. Chem, 46(10), 5120–5126. doi.org/10.1016/j.ejmech.2011.08.026
16. Liou, J. P., Hsu, K. S., Kuo, C. C., Chang, C. Y., & Chang, J. Y. (2007) A novel oral indoline-sulfonamide agent, J30, exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule. J. Pharmacol. Exp. Ther, 323(1), 398-405.
17. Chen, Z., Xu, W., Liu, K., Yang, S., Fan, H., Bhadury, P. S., ... & Zhang, Y. (2010) Synthesis and Antiviral Activity of 5 (4 Chlorophenyl)-1, 3, 4-Thiadiazole Sulfonamides. Molecules, 15(12), 9046-9056.
18. Scozzafava, A., Owa, T., Mastrolorenzo, A., & Supuran, C. T. (2003) Anticancer and antiviral sulfonamides. Curr. Med. Chem., 10(11), 925-953.
19. Shoaib Ahmad Shah, S., Rivera, G., & Ashfaq, M. (2013). Recent advances in medicinal chemistry of sulfonamides. Rational design as anti-tumoral, anti-bacterial and anti-inflammatory agents. Mini Rev. Med. Chem., 13(1), 70-86.
20. Jagannath, K. V, Krishnamurthy, G., & Raghavaiah P. (2018) Synthesis, crystal structure and thermal studies of 2-(propan-2-yl) pyrimido [1,2-a] benzimidazol -4(10H)-one. Proceedings of Int. Conference Recent Advances in Materials Science and Biophysics (RAMSB)-2018, 1, 13-17.